Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Clindamycin Versus Standard of Care for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled, Open-label Superiority Phase 4 Trial

NCT05899140 is registered in ClinicalTrials.gov with Frieder Schaumburg as lead sponsor.

NCT NCT05899140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Clindamycin Versus Standard of Care for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled, Open-label Superiority Phase 4 Trial
Lead sponsor
Frieder Schaumburg
Phase
Phase 4
Overall status
Recruiting
Start date
March 15, 2024
Completion date
July 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin infection, staphylococcal infections, staphylococcus aureus infection